Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02311153 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT02311153 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 104 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02311153, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

Laryngeal mask airways (LMA) have been shown to be a safe mode of airway management when delivering general anesthesia to patients during a variety of operative procedures. LMA's have been studied in a wide range of otolaryngologic procedures, and are generally safe and accepted by both anesthesia providers and surgeons alike. This study will aim to demonstrate the safety and efficacy of LMA for airway management during sinonasal surgery by directly comparing them to endotracheal intubation in a prospective randomized single-blind study.

Interventions

  • DEVICE Mallinckrodt Endotracheal Tube (ETT)
  • DEVICE Laryseal Laryngeal mask airway (LMA)

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2014-11-25
Est. Completion 2017-12
Phase NA

What the Registry Record Tells You About NCT02311153

The ClinicalTrials.gov registry entry for NCT02311153 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mallinckrodt Endotracheal Tube (ETT) is the first listed.

NCT02311153 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02311153 about?

NCT02311153 is a clinical study titled "Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery". Laryngeal mask airways (LMA) have been shown to be a safe mode of airway management when delivering general anesthesia to patients during a variety of operative procedures. LMA's have been studied in a wide range of otolaryngologic procedures, and are generally safe and accepted by both anesthesia p...

What is the current status of trial NCT02311153?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2014-11-25. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02311153?

The interventions under investigation include: Mallinckrodt Endotracheal Tube (ETT) (DEVICE), Laryseal Laryngeal mask airway (LMA) (DEVICE).

Who is sponsoring clinical trial NCT02311153?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.